Moreover, the expression of CD86, the corresponding immune ligand of CTLA4, was not reduced, but the expression of CERCAM-1, the ligand of TIM3, was slightly reduced in CL83 and H522 cancer cell lines (fig. Here, CD86 is linked to cancer.